Kintsugi Company
Kintsugi detects signs of clinical depression and anxiety using machine learning and voice biomarkers.
Investors
Connections from
Last Funding Type:
Series A
Funding Status:
Early Stage Venture
Headquarters:
Berkeley, California, United States
Founded Date:
2019-01-01
Last Funding Date:
2022-02-28
Total Funding:
30875772
Employee Number:
11-50
Investors Number:
19
Industry:
NeuroTech